Literature DB >> 11665605

Crystallization of complex between soluble domains of adenylyl cyclase and activated Gs alpha.

John J G Tesmer1, Roger K Sunahara, David A Fancy, Alfred G Gilman, Stephen R Sprang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11665605     DOI： 10.1016/s0076-6879(02)45017-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

1.  Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate.

Authors:  Melanie Hübner; Anshuman Dixit; Tung-Chung Mou; Gerald H Lushington; Cibele Pinto; Andreas Gille; Jens Geduhn; Burkhard König; Stephen R Sprang; Roland Seifert
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

2.  Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.

Authors:  Srividya Suryanarayana; Martin Göttle; Melanie Hübner; Andreas Gille; Tung-Chung Mou; Stephen R Sprang; Mark Richter; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2009-06-03       Impact factor: 4.030

3.  Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".

Authors:  Nicole Toohey; Michael T Klein; Jessica Knight; Carol Smith; Milt Teitler
Journal:  Mol Pharmacol       Date:  2009-06-09       Impact factor: 4.436

4.  Structural basis for inhibition of mammalian adenylyl cyclase by calcium.

Authors:  Tung-Chung Mou; Nanako Masada; Dermot M F Cooper; Stephen R Sprang
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.